Example: Heart Attack

Search clinical trials for: 68Ga-FAPI-RGD

Total 2493 results

NCT06054789

Recruiting

Clinical Study on 68Ga-PSMA-33 for PET/CT Imaging of Prostate Cancer

Prostate Cancer
NCT06125028

Terminated

[68Ga]Ga-PentixaFor-PET Imaging for Staging of Marginal Zone Lymphoma (LYMFOR)

Marginal Zone Lymphoma
NCT04230135

Terminated

Cultural Adaptation of Hap-pas-Hapi (Step-by-Step) for Albanian-speaking Immigrants in Switzerland and Germany

Psychological Distress
NCT07572383

Recruiting

Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis

Pulmonary Fibrosis | Interstitial Lung Disease
NCT05673031

Recruiting

68Ga-HA-DOTATATE PET/CT in Adults With Neuroendocrine Tumors

Neuroendocrine Tumors (NET)
NCT05346276

Completed

68Ga-DOTA-hLAG-3 PET Imaging of LAG-3 Expression in Cancers

PET/CT | hLAG-3 | TUMOR
NCT05728515

Completed

A Small-molecule Carbonic Anhydrase IX Targeting PET Tracer in Clear Cell Renal Cell Carcinoma

Clear Cell Renal Cell Carcinoma
NCT03911310

Completed

[18F]PSMA-11 PET/CT Phase 3 Clinical Study (NGP3)

Prostate Cancer
NCT05192694

Recruiting

Evaluation of Fapi-pet in Prostate Cancer. (FAPIPETPCA)

Prostate Cancer
NCT07500987

Recruiting

Phase I Study of [111In]-FPI-2107 in EGFR Mutation-positive NSCLC

EGFR Mutation-positive NSCLC
NCT02282137

Recruiting

68Ga-PSMA PET-CT Scan for Diagnosis and Management of Prostate Cancer (PSMA)

Prostate Cancer
NCT05859763

Recruiting

99mTc-HFAPI SPECT/CT in Pulmonary Fibrosis

Pulmonary Fibrosis
NCT05224700

Not yet recruiting

Early Development of Academic Skills in the Classroom (JAPI)

General Population of Children Aged 3 to 5 Years Old
NCT06756217

Recruiting

68Ga-grazytracer PET/CT for Early Assessment of Response to Neoadjuvant Immunotherapy in Resectable NSCLC

Non-Small Cell Lung Cancer
NCT05706129

Recruiting

A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors

Triple Negative Breast Cancer (TNBC) | Pancreatic Ductal Adenocarcinoma (PDAC) | Colorectal Cancer (CRC) | Clear Cell Renal Cell Cancer (ccRCC) | Urothelial Carcinoma (UC) | Indeterminate Renal Mass (IDRM) | Muscle Invasive Bladder Cancer (MIBC) | Head and Neck Cancer (H&N) | Squamous Non-Small Cell Lung Cancer (NSCLC)
NCT05048810

Completed

Clinical Application of 68Ga-DOTA-NT-20.3 in the Early Diagnosis of Pancreatic Ductal Adenocarcinoma

Pancreatic Ductal Adenocarcinoma
NCT03648073

Completed

[68Ga]DOTATATE-PET/MRI in Hepatocellular Carcinoma

Hepatocellular Carcinoma
NCT03385148

Unknown

The Clinical Application of 68Ga Labeled ssDNA Aptamer Sgc8 in Healthy Volunteers and Colorectal Patients

Colorectal Cancer
NCT02970786

Unknown

Phase I Trial: 68Ga-NODAGA-E(c[RGDyK])2 Positron Emission Tomography for Imaging Angiogenesis in Primary and Metastatic Tumor Lesions in Humans

Breast Cancer | Ovarian Cancer | Neuroendocrine Carcinoma
NCT06289517

Recruiting

PET Imaging of 68Ga-Her2-affibody in Tumors with High Her2 Expression

Neoplasms
NCT05799274

Recruiting

Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors (RAD301)

Cervical Cancer | Ovarian Cancer | Healthy Volunteers | Endometrial Cancer | Non-small Cell Lung Cancer (NSCLC) | Pancreatic Ductal Adenocarcinoma | Esophageal Squamous Cell Carcinoma
NCT07285993

Not yet recruiting

Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET

Breast Cancer | Metastatic Invasive Lobular Breast Cancer
NCT06763354

Recruiting

The Efficacy of Gallium[68Ga]NOTA-DNA Multivalent SGC8 Injection for Bladder Tumour Imaging

Bladder Cancer
NCT05619302

Completed

Molecular Imaging of Myocardial Fibrosis in Cardiac Amyloidosis

Cardiac Amyloidosis
NCT03490032

Completed

68Ga-PSMA-R2 in Patients With Biochemical Relapse (BR) and Metastatic Prostate Cancer (mPCa) (PROfind)

Prostate Cancer Metastatic
NCT02327442

Unknown

68Ga-NOTA-NFB: Radiation Dosimetry in Healthy Volunteers and Applications in Glioma Patients or Breast Cancer Patients (GNNGB)

Glioma | Breast Cancer
NCT04049890

Recruiting

Development and Validation of Family Adjustment Inventory

Adjustment Reaction
NCT07014254

Not yet recruiting

Therapeutic Study of 177Lu-CTR-FAPI in Advanced Metastatic Digestive Malignancies

Colorectal Cancer Metastatic | Adenocarcinoma of the Stomach | Pancreatic Ductal Adenocarcinoma (PDAC) | Neuroendocrine Tumor (NET)
NCT06147037

Recruiting

A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours

Renal Cell Carcinoma | Gastric Cancer | Advanced Solid Tumor | Non-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Pancreatic Ductal Adenocarcinoma | Metastatic Colorectal Carcinoma
NCT07593209

Recruiting

First-in-Human Study of the Radioligand 68Ga- DOTA-EphA2 (EphA2)

Malignant Tumor
NCT07366099

Recruiting

Al18F-NOTA-LM3 PET/CT in Patients With TIO

Tumor-Induced Osteomalacia
NCT07353554

Not yet recruiting

Application Study of 68Ga-NOTA-BCMA Nanoantibody Imaging in Multiple Myeloma

Multiple Myeloma (MM)
NCT06203587

Recruiting

Clinical Study of GPA33-specific PET/CT for the Diagnosis of Colorectal Cancer

Colorectal Neoplasms | Positron-Emission Tomography
NCT00805376

Completed

DNX-2401 (Formerly Known as Delta-24-RGD-4C) for Recurrent Malignant Gliomas

Central Nervous System Diseases | Brain Cancer
NCT06602037

Recruiting

ImmunoPET Imaging of Pancreatic Cancer

Neoplasms Pancreatic
NCT03001869

Completed

68Ga-PSMA PET/CT in Prostate Cancer

Prostate Cancer
NCT07067905

Recruiting

Clinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell Carcinoma

Clear Cell Renal Cell Carcinoma and Glioblastoma
NCT04040166

Completed

Carotid PET/MRI With DOTATATE in Patients Post Head and Neck Radiation Therapy

Head & Neck Cancer
NCT04904120

Completed

Targeted Imaging of Melanoma for Alpha-Particle Radiotherapy (TIMAR1)

Melanoma (Skin) | Melanoma Stage IV | Melanoma, Uveal | Melanoma, Mucosal
NCT03746431

Terminated

A Phase 1 Study of [225Ac]-FPI-1434 Injection

Cervical Cancer | Breast Cancer | Ovarian Cancer | Endometrial Cancer | Uveal Melanoma | Adrenocortical Carcinoma | Advanced Solid Tumours | HER2-negative Breast Cancer | Triple Negative Breast Cancer (TNBC) | Head and Neck Squamous Cell Carcinoma (HNSCC)
NCT01737606

Completed

Ultrasonic Explorations of Cerebral Tissue Motions - Influence of Aging (COSTUM)

Aging | Cerebral Pulsatility
NCT07121244

Recruiting

A Phase 1 Study of 68Ga-R11228 and 177Lu-R11228 in Breast Cancer

Locoregionally Recurrent Hormone-receptor Positive Breast Cancer | Metastatic Hormone Receptor Positive Breast Cancer
NCT07045428

Not yet recruiting

68Ga-GP-01 Injection in Solid Tumors Participants

Solid Tumor Malignancies
NCT05622227

Recruiting

68Ga PET/CT Imaging in Breast Cancer Patients

Breast Cancer
NCT04847505

Recruiting

68Ga-DOTA-TATE PET/CT Imaging in NETs

Neuroendocrine Tumors
NCT06443762

Completed

First Human Trial of Targeting MDM2/MDMX PET Imaging

Nuclear Medicine | MDM2/MDMX Gene Mutation | Positron Emission Tomography Imaing
NCT00001277

Completed

Studies of Elevated Parathyroid Activity

Hyperparathyroidism | Multiple Endocrine Neoplasia | Hypercalcemia | MEN1 | Parathyroid Neoplasm
NCT03724253

Terminated

[68Ga]-NeoBOMB1 Imaging in Patients With Malignancies Known to Overexpress Gastrin Releasing Peptide Receptor (GRPR) (NeoFIND)

Breast Cancer | Small Cell Lung Cancer | Colorectal Cancer | Prostate Cancer | Non Small Cell Lung Cancer
NCT02162446

Completed

68Ga-OPS202 Study for Diagnostic Imaging of GEP NET

Gastroenteropancreatic Neuroendocrine Tumors
NCT02681640

Completed

uPAR PET/CT for Preoperative Staging of Breast Cancer Patients

Breast Cancer

Search clinical trials for: 68Ga-FAPI-RGD

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations